US41358P2056 - Common Stock
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.
These are the best dividend growth stocks to buy as they represent companies with healthy free cash flow upside visibility.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Merck (MRK) said the FDA has approved Keytruda in combination with chemoradiotherapy for the treatment of FIGO 2014 Stage III-IVA cervical cancer. Read more here.
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
On the back of recent deals involving big pharma, Barron’s issued positive remarks on a possible acceleration of biotech M&A activity on Tuesday. Read more here.
Harpoon Therapeutics could attract other bidders after agreeing to a $23 per share sale to Merck, according to an Oppenheimer analyst.
More than $6.4 billion in health-care deals were announced on Monday at the annual JPMorgan Healthcare Conference in San Francisco as companies like Johnson & Johnson and Merck & Co. look to acquisitions to replenish their revenue streams.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Ademi LLP is investigating Harpoon (Nasdaq: HARP) for possible breaches of fiduciary duty and other violations of law in its transaction with...
The year's biggest medical conference kicked off with a melee of buyout news.
Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!